Frank Azzopardi
Lawyers

Filters
Pure Storage $425 Million Initial Public Offering
Davis Polk advised the underwriters in connection with an initial public offering of 25,000,000 shares of Class A common stock of Pure Storage, Inc. at $17.00 per share for gross proceeds…
Davis Polk Advises Penumbra, Inc. on Its $138 Million Initial Public Offering
Davis Polk advised Penumbra, Inc. on its SEC-registered initial public offering of 4,600,000 shares of common stock for an aggregate price to the public of approximately $138 million,…
Seattle Genetics, Inc. $552 Million Equity Offering
Davis Polk advised the underwriters, in connection with an SEC-registered offering by Seattle Genetics, Inc. of 13,463,415 shares of common stock, which includes 1,756,097 shares of common…
Davis Polk Advises SS&C on Its Acquisition of Primatics Financial
Davis Polk is advising SS&C Technologies Holdings, Inc. in connection with its approximately $122 million acquisition of Primatics Financial from The Carlyle Group. The acquisition is…
MSCI Inc. $800 Million Notes Offering
Davis Polk advised MSCI Inc. (“MSCI”) in connection with a Rule 144A/Regulation S offering of $800 million aggregate principal amount of its 5.750% senior notes due 2025. The notes are…
Celgene $8.0 Billion Notes Offering
Davis Polk advised the joint book-running managers on an SEC-registered offering by Celgene Corporation of $8.0 billion aggregate principal amount of notes. The notes were issued in…
Energizer SpinCo, Inc. $650 Million Credit Facilities
Davis Polk advised the joint lead arranger and bookrunner, and the administrative agent, in connection with the $650 million senior secured credit facilities (the “Facilities”) provided to…
Davis Polk Advises Tailwind Capital on the Sale of ReTrans
Davis Polk is advising Tailwind Capital in connection with the sale of ReTrans Inc. to The Kuehne + Nagel Group. The transaction is subject to approval by regulatory authorities.
Tailwind…
Cynapsus Therapeutics Inc. $72.5 Million Initial Public Offering
Davis Polk advised the underwriters in connection with the $72.5 million U.S. initial public offering of 5,175,000 common shares of Cynapsus Therapeutics Inc., including 675,000 common…
Avid Technology, Inc. $125 Million Convertible Senior Notes Offering
Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Avid Technology, Inc.(“Avid”) of an aggregate principal amount of $125 million of its 2.00% convertible…